Si-chong Han
State Key Laboratory Of Molecular Oncology And Department Of Molecular Oncology, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Oncogenic functions and therapeutic potentials of targeted inhibition of SMARCAL1 in small cell lung cancer" [Cancer Lett. 592, (2024), 216929].
Journal: Cancer letters
Published: August 28, 2026
Corrigendum to "CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancers" [Cancer Lett. 628 (2025) 217822].
Journal: Cancer letters
Published: July 22, 2026
Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers.
Journal: Signal transduction and targeted therapy
Published: February 07, 2025
Air pollution, EGFR mutation, and cancer initiation.
Journal: Cell reports. Medicine
Published: April 18, 2023
Nuclear AhR and membranous PD-L1 in predicting response of non-small cell lung cancer to PD-1 blockade.
Journal: Signal transduction and targeted therapy
Published: September 27, 2022
Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1.
Journal: Signal transduction and targeted therapy
Published: March 04, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026